Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $700K in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.Data for Adamis Pharmaceuticals | ADMP - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.24M in Stock for its fiscal quarter ending in December of 2022. Data for Adamis Pharmaceuticals | ADMP - Stock including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterNon-traditional data signals from social media and employment platforms for ADMP stock analysis
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported 10.1M in Outstanding Shares in April of 2024. Data for Adamis Pharmaceuticals | ADMP - Outstanding Shares including historical, tables and charts were last updated by Trading Economics this last November in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $9.06K in Sales Revenues for its fiscal quarter ending in September of 2023. Data for Adamis Pharmaceuticals | ADMP - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $15.05K in Ordinary Share Capital for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Ordinary Share Capital including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in March of 2022. Data for Adamis Pharmaceuticals | ADMP - Loan Capital including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.85M in Debt for its fiscal quarter ending in March of 2022. Data for Adamis Pharmaceuticals | ADMP - Debt including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-8.94M in Net Income for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Net Income including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported 11 in Employees for its fiscal year ending in December of 2022. Data for Adamis Pharmaceuticals | ADMP - Employees Total Number including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
Twitterstock_info.json: has all the information for each symbol present in the data files.
Files name with the respective symbols data present: | file_name | ticker_list_str | |----------------------------|----------------------| | stocks_data_1.csv | A,AA,AAC,AACG,AACI,AACIW,AACT,AADI,AAIC,AAIN,AAL,AAMC,AAME,AAN,AAOI,AAON,AAP,AAPL,AAT,AAU,AB,ABBV,ABCB,ABCL,ABCM,ABEO,ABEV,ABG,ABIO,ABL,ABLLW,ABLV,ABLVW,ABM,ABNB,ABOS,ABR,ABSI,ABT,ABUS,ABVC,AC,ACA,ACAB,ACABW,ACACU,ACACW,ACAD,ACAQ,ACAX,ACAXR,ACAXU,ACAXW,ACB,ACBA,ACBAW,ACCD,ACCO,ACDC,ACDCW,ACEL,ACER,ACET,ACGL,ACGLN,ACGLO,ACHC,ACHL,ACHR,ACHV,ACI,ACIC,ACIU,ACIW,ACLS,ACLX,ACM,ACMR,ACN,ACNB,ACNT,ACON,ACONW,ACOR,ACP,ACR,ACRE,ACRO,ACRS,ACRV,ACRX,ACST,ACT,ACTG,ACU,ACV,ACVA,ACXP,ADAG,ADAP,ADBE,ADC,ADCT,ADD,ADEA,ADER,ADERW,ADES,ADEX,ADI,ADIL,ADM,ADMA,ADMP,ADN,ADNT,ADNWW,ADOC,ADOCR,ADOCW,ADP,ADPT,ADRT,ADSE,ADSEW,ADSK,ADT,ADTH,ADTHW,ADTN,ADTX,ADUS,ADV,ADVM,ADVWW,ADX,ADXN,AE,AEAE,AEAEW,AEE,AEF,AEFC,AEG,AEHL,AEHR,AEI,AEIS,AEL,AEM,AEMD,AENT,AENZ,AEO,AEON,AEP,AER,AES,AESC,AESI,AEVA,AEY,AEYE,AEZS,AFAR,AFARU,AFB,AFBI,AFCG,AFG,AFGB,AFGC,AFGD,AFGE,AFIB,AFL,AFMD,AFRI,AFRIW,AFRM,AFT,AFYA,AG,AGAE,AGBA,AGBAW,AGCO,AGD,AGE,AGEN,AGFY,AGI,AGIL,AGILW,AGIO,AGL,AGLE,AGM,AGMH,AGNC,AGNCL,AGNCM,AGNCN,AGNCO,AGNCP,AGO,AGR,AGRI,AGRIW,AGRO,AGRX,AGS,AGTI,AGX,AGYS,AHCO,AHG,AHH,AHI,AHT,AI,AIBBR,AIC,AIF,AIG,AIH,AIHS,AIM,AIMAU,AIMAW,AIMBU,AIMD,AIMDW,AIN,AINC,AIO,AIP,AIR,AIRC,AIRG,AIRI,AIRS,AIRT,AIRTP,AIT,AIU,AIV,AIXI,AIZ,AIZN,AJ...
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-6.32M in EBITDA for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Ebitda including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.79M in Cost of Sales for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Cost Of Sales including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-8.33M in Pre-Tax Profit for its fiscal quarter ending in June of 2022. Data for Adamis Pharmaceuticals | ADMP - Pre Tax Profit including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $9.78M in Trade Creditors for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Trade Creditors including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $10 in Interest Income for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Interest Income including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $0 in Interest Expense on Debt for its fiscal quarter ending in March of 2022. Data for Adamis Pharmaceuticals | ADMP - Interest Expense On Debt including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $7.55M in Current Assets for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Current Assets including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $4.78M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Selling And Administration Expenses including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-0.06 in EPS Earnings Per Share for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - EPS Earnings Per Share including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $700K in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.Data for Adamis Pharmaceuticals | ADMP - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last December in 2025.